Montalbano John S. — SEC Form 4 filings
SEC reporting owner CIK 1834423. 8 Form 4 filings on record with FilingPulse; latest filed 2026-08-18.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-06-24 to 2026-08-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 5 filings — 165,000 shares, $582,228 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 3.
- Largest priced transaction: purchase of 50,000 shares @ $3.57 ($178,460) in AbCellera Biologics Inc., filed 2025-11-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| AbCellera Biologics Inc. (ABCL) | Director | 8 | 5 legs · 165,000 sh · $582,228 | — | 3 |
Form 4 filings — Montalbano John S.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-18 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 10,000 @ $11.03 | EDGAR |
| 2026-06-12 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 111,701 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 20,000 @ $4.77 | EDGAR |
| 2025-11-26 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 50,000 @ $3.57 | EDGAR |
| 2025-06-16 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 238,864 (derivative) @ $0 | EDGAR |
| 2025-03-10 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 25,000 @ $2.30 | EDGAR |
| 2025-03-07 | 4 | AbCellera Biologics Inc. (ABCL) | Purchase (P): 60,000 @ $2.34 | EDGAR |
| 2024-06-24 | 4 | AbCellera Biologics Inc. (ABCL) | Grant/award (A): 163,934 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1834423 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →